Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding

Table 3 Proportions of 1-, 3-, and 5-year cumulative variceal rebleeding, abnormal liver function, and hepatocellular carcinoma in the two groups before and after propensity score matching, %

Outcome/Time	Before PSM			After PSM
	SPD group	TIPS group	P value1	SPD group	TIPS group	P value1
Variceal rebleeding
1-yr	8.60	20.50	0.001	7.80	11.10	0.09
3-yr	19.10	34.60		15.65	27.80
5-yr	24.10	37.80		23.30	31.10
Abnormal liver function
1-yr	13.60	48.70	< 0.001	13.30	46.70	< 0.001
3-yr	19.80	57.70		18.90	53.30
5-yr	22.80	60.30		20.00	56.70
Hepatocellular carcinoma
1-yr	2.50	3.80	0.03	2.20	4.40	0.02
3-yr	3.70	9.00		2.20	10.00
5-yr	4.90	11.50		2.20	12.20

¹Log-rank test was used to compare the differences between the two groups for each outcome event. SPD: Splenectomy plus pericardial devascularization; TIPS: Transjugular intrahepatic portosystemic shunt; PSM: Propensity score-matched analysis.